SAN FRANCISCO--(BUSINESS WIRE)--Jun 12, 2024-- A landmark debate titled "How to Defeat Aging," held by Open Longevity at the Foresight Institute on May 27, 2024, produced an unexpected winner, uncovering a far more nuanced narrative behind the recent surge of interest to rejuvenation biotechnology. The event pitted two leading scientists Dr. Aubrey de Grey and Dr.
Peter Fedichev against each other, each offering contrasting perspectives on the future of aging research. This press release features multimedia. View the full release here: https://www.
businesswire.com/news/home/20240612410231/en/ Longevity debates poster (Graphic: Business Wire) Dr. Aubrey de Grey, president and chief science officer of the Longevity Escape Velocity (LEV) Foundation , a renowned advocate for rejuvenation therapies, argued that aging is a process caused by accumulated damage, which could potentially be repaired through targeted interventions.
Dr. Peter Fedichev, CEO of Gero.ai , one of the thought leaders in longevity and another proponent of radical biotech solutions to the aging problem, who applies quantitative models of human aging, challenged de Grey’s optimistic view on rejuvenation.
Dr. Fedichev emphasized the inherent limitations posed by the stochastic (random) and thermodynamically irreversible nature of human aging, suggesting that rejuvenation might offer only around 15 additional years of lifespan at best. According to Fedichev, with current technologies, we have the potential to li.